Just for fun, some wild speculation as I like to do from time to time. You might want to double check my sums or assumptions.
The base figure I'm using for heart failure is from a translated page 3 of the Tasly Pharmaceutical Group Co., Ltd. disclosure document,
The prevalence of heart failure in China is 1.3%, and it is estimated that there are at least 10 million patients with different degrees.
So I will take that at 10% of 10 million, 1 million people who might need treatment to begin with, at a fairly conservative, I hope, $10,000 per treatment dose, should only be once per patient if it works as planned.
That gives $10,000,000,000 or $10 billion, in your currency of choice, to treat 1 million people per annum and we know the royalty is double digits so I will take the lowest at 10%.
That makes One Billion dollars payable to MSB.
Would that make a difference to the share price?
And there are probably some other products too, in other countries.
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly, page-201
-
- There are more pages in this discussion • 92 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 0.935 |
12 | 175098 | 0.930 |
7 | 101559 | 0.925 |
8 | 126323 | 0.920 |
10 | 99179 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 14089 | 2 |
0.950 | 32015 | 3 |
0.955 | 49989 | 4 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online